Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User — Global Forecast till 2023
ID: MRFR/HC/6063-HCR | February 2021 | Region: Global | 160 pages
Market Scenario
The global microbiome sequencing services market is expected to grow significantly over the forecast period. It is estimated that the global microbiome sequencing services market is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2023, with an estimated market value of USD 555.1 million in 2017. A microbiome is the unique collection of trillions of microorganisms in and on an individual’s body. Microbiome sequencing is a diagnostic technique in which millions and billions of DNA strands can be parallelly sequenced.
The market of microbiome sequencing services is driven by factors such as rising demand for microbiome research, high investment in next-generation sequencing, and reduction in the cost of next-generation sequencing. For instance, according to the data published by the Wall Street Journal in 2016, venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015. Additionally, widening applications of microbiome sequencing and rise in the genome mapping programs are propelling the growth of the market.
On the other hand, the lack of skilled technicians, ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is thwarting the growth of microbiome sequencing services market to an extent.
Moreover, major companies in the market are involved in strategic collaborations to sustain their position in the market. For instance, in November 2017, Microbiome Therapeutics, LLC launched the first microbiome modulator. This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
Segmentation
The global microbiome sequencing services market has been segmented into technology, application, and end user. The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others. The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others. The market, by end user, has been segmented into research and academic institutes, pharmaceutical and biotechnology companies, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The microbiome sequencing services market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European microbiome sequencing services market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The microbiome sequencing services market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The microbiome sequencing services market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Global Microbiome Sequencing Services Market Share (%), by Region, 2017
Source: World Health Organization (WHO), Institute of Medicine (IOM)
Geographically, the Americas is expected to dominate the global microbiome sequencing services market due to the increasing per capita healthcare expenditure, and the heavy adoption of new technology. Furthermore, rising expenses in research and development by healthcare bodies and the government is anticipated to drive the growth of the market in this region.
Europe showed a considerable amount of growth in the global microbiome sequencing services market. The market growth in this region is because of the presence of a well-established healthcare system and increase in chronic diseases. For instance, according to cancer research UK, there were approximately 9, 921 cases of cancer diagnosed in 2015. Such high rates of cancer are likely to increase demand for use of next-generation sequencing as well as increase the market demands for monoclonal bodies and cellular research. These factors are expected to have a positive impact on the microbiome sequencing services market.
Asia-Pacific is expected to have a sturdy growth rate during the forecast period owing to the huge patient pool of chronic diseases and government initiatives of healthcare reforms. However, less capital investment and awareness regarding healthcare IT are restricting the market growth of this region.
On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income. Moreover, the limited adoption of advanced healthcare facilities and limited access to treatment facilities is also expected to drive the growth of the market in the near future.
Global Microbiome Sequencing Services Market, by Technology
- Sequencing by Litigation (SBL)
- Sequencing by Synthesis (SBS)
- Short Gun Sequencing
- Targeted Gene Sequencing
- RNA Sequencing
- Others
Global Microbiome Sequencing Services Market, by Application
- Gastrointestinal Diseases
- Infectious Diseases
- CNS Diseases
- Oncology
- Others
Global Microbiome Sequencing Services Market, by End User
- Research and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Others
Global Microbiome Sequencing Services Market, by Region
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Global Microbiome Sequencing Services Market, by Key Players
- Baseclear B.V.
- Clinical Microbiomics A/S
- EPIBIOME
- Merieux Nutrisciences Corporations
- Metabiomics Corp.
- Microbiome Insights Inc.
- Microbiome Therapeutics, LLC.
- MR DNA
- Rancho Biosciences
- Second Genome
- Ubiome, Inc.
- Zymo Research Corp.
Intended Audience
- Pharmaceutical Companies
- Research and Development (R&D) Companies
- Government Research Institutes
- Academic Institutes and Universities
- Venture Capitalists
Frequently Asked Questions (FAQ) :
The global microbiome sequencing services market was valued at USD 555.1 million in 2017.
The market is expected to exhibit a robust 19.22% CAGR over the forecast period from 2018 to 2023.
The rising demand for microbiome research and next-generation sequencing is the major driver for the market.
The Americas hold the dominant share in the market.
Leading players in the microbiome sequencing services market include Baseclear, EPIBIOME, Metabiomics, MR DNA, Ubiome, and Zymo Research Corp., among others.
Table of Contents:
Chapter 1 Report Prologue
Chapter 2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3 Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Opportunity Analysis
5.4 Pricing Analysis
Chapter 6 Global Microbiome Sequencing Services Market, by Technology
6.1 Overview
6.2 Sequencing by Litigation (SBL)
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.3 Sequencing by Synthesis (SBS)
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.4 Short Gun Sequencing
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.5 Targeted Gene Sequencing
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.6 RNA Sequencing
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.7 Others
Chapter 7 Global Microbiome Sequencing Services Market, by Application
7.1 Overview
7.2 Gastro-Intestinal Diseases
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.3 Infectious Diseases
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.4 CNS Diseases
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.5 Oncology
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.6 Others
Chapter 8 Global Microbiome Sequencing Services Market, by End User
8.1 Overview
8.2 Research and Academic Institutes
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.3 Pharmaceutical and Biotechnology Companies
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.4 Others
Chapter 9 Global Microbiome Sequencing Services Market, by Region
9.1 Overview
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 Latin America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
Chapter 11 Company Profiles
11.1 Baseclear B.V.
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Clinical Microbiomics A/S
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 EPIBIOME
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Merieux Nutrisciences Corporations
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Metabiomics Corp.
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Microbiome Insights Inc.
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Microbiome Therapeutics, LLC.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 MR DNA
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Rancho Biosciences
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Second Genome
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Ubiome, Inc.
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Zymo Research Corp.
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Microbiome Sequencing Services Industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Global Microbiome Sequencing Services Market Synopsis, 2018–2023
Table 2 Global Microbiome Sequencing Services Market Estimates and Forecast, 2018–2023 (USD Million)
Table 3 Global Microbiome Sequencing Services Market, by Technology, 2018–2023 (USD Million)
Table 4 Global Microbiome Sequencing Services Market, by Application, 2018–2023 (USD Million)
Table 5 Global Microbiome Sequencing Services Market, by End User, 2018–2023 (USD Million)
Table 6 Global Microbiome Sequencing Services Market, by Region, 2018–2023(USD Million)
Table 7 North America: Microbiome Sequencing Services Market, by Technology, 2018–2023 (USD Million)
Table 8 North America: Microbiome Sequencing Services Market, by Application, 2018–2023 (USD Million)
Table 9 North America: Microbiome Sequencing Services Market, by End User, 2018–2023 (USD Million)
Table 10 North America: Microbiome Sequencing Services Market, by Country, 2018–2023 (USD Million)
Table 11 Latin America: Microbiome Sequencing Services Market, by Technology, 2018–2023 (USD Million)
Table 12 Latin America: Microbiome Sequencing Services Market, by Application, 2018–2023 (USD Million)
Table 13 Latin America: Microbiome Sequencing Services Market, by End User, 2018–2023 (USD Million)
Table 14 Europe: Microbiome Sequencing Services Market, by Technology, 2018–2023 (USD Million)
Table 15 Europe: Microbiome Sequencing Services Market, by Application, 2018–2023 (USD Million)
Table 16 Europe: Microbiome Sequencing Services Market, by End User, 2018–2023 (USD Million)
Table 17 Europe: Microbiome Sequencing Services Market, by Region, 2018–2023 (USD Million)
Table 18 Western Europe: Microbiome Sequencing Services Market, by Technology, 2018–2023 (USD Million)
Table 19 Western Europe: Microbiome Sequencing Services Market, by Application, 2018–2023 (USD Million)
Table 20 Western Europe: Microbiome Sequencing Services Market, by End User, 2018–2023 (USD Million)
Table 21 Western Europe: Microbiome Sequencing Services Market, by Country, 2018–2023 (USD Million)
Table 22 Eastern Europe: Microbiome Sequencing Services Market, by Technology, 2018–2023 (USD Million)
Table 23 Eastern Europe: Microbiome Sequencing Services Market, by Application, 2018–2023 (USD Million)
Table 24 Eastern Europe: Microbiome Sequencing Services Market, by End User, 2018–2023 (USD Million)
Table 25 Asia-Pacific: Microbiome Sequencing Services Market, by Technology, 2018–2023 (USD Million)
Table 26 Asia-Pacific: Microbiome Sequencing Services Market, by Application, 2018–2023 (USD Million)
Table 27 Asia-Pacific: Microbiome Sequencing Services Market, by End User, 2018–2023 (USD Million)
Table 28 Asia-Pacific: Microbiome Sequencing Services Market, by Country, 2018–2023 (USD Million)
Table 29 Middle East & Africa: Microbiome Sequencing Services Market, by Technology, 2018–2023 (USD Million)
Table 30 Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2018–2023 (USD Million)
Table 31 Middle East & Africa: Microbiome Sequencing Services Market, by End User, 2018–2023 (USD Million)
Table 32 Middle East & Africa: Microbiome Sequencing Services Market, by Region, 2018–2023 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Microbiome Sequencing Services Market
Figure 3 Segmentation Market Dynamics for Global Microbiome Sequencing Services Market
Figure 4 Global Microbiome Sequencing Services Market Share, by Technology, 2017 (%)
Figure 5 Global Microbiome Sequencing Services Market Share, by Application, 2017 (%)
Figure 6 Global Microbiome Sequencing Services Market Share, by End User, 2017 (%)
Figure 7 Global Microbiome Sequencing Services Market Share, by Region, 2017 (%)
Figure 8 North America: Microbiome Sequencing Services Market Share, by Country, 2017 (%)
Figure 9 Europe: Microbiome Sequencing Services Market Share, by Region, 2017 (%)
Figure 10 Western Europe: Microbiome Sequencing Services Market Share, by Country, 2017 (%)
Figure 11 Asia-Pacific: Microbiome Sequencing Services Market Share, by Country, 2017 (%)
Figure 12 Middle East & Africa: Microbiome Sequencing Services Market Share, by Country, 2017 (%)
Figure 13 Global Microbiome Sequencing Services Market: Company Share Analysis, 2017 (%)
Figure 14 Baseclear B.V.: Key Financials
Figure 15 Baseclear B.V.: Segmental Revenue
Figure 16 Baseclear B.V.: Geographical Revenue
Figure 17 Clinical Microbiomics A/S: Key Financials
Figure 18 Clinical Microbiomics A/S: Segmental Revenue
Figure 19 Clinical Microbiomics A/S: Geographical Revenue
Figure 20 Microbiome Insights Inc.: Key Financials
Figure 21 Microbiome Insights Inc.: Segmental Revenue
Figure 22 Microbiome Insights Inc.: Geographical Revenue
Figure 23 Merieux Nutrisciences Corporation: Key Financials
Figure 24 Merieux Nutrisciences Corporation: Segmental Revenue
Figure 25 Merieux Nutrisciences Corporation: Geographical Revenue
NOTE:
This table of content is tentative and subject to change as the research progresses.
-In Chapter 11, the top 10 companies will be profiled. Each company will be profiled on the basis of Market Overview, Financials, Product Portfolio, Business Strategies, & Recent Development parameters.
-Please note: Financial details of the company cannot be provided if the information of the company is not available in the public domain and or reliable source
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.
